SBIR/STTR Research Award

Neuromodulation for Stroke Shoulder Pain

Award identifier a077eb68c24abc06cdb982210700860258341437a762eb1e2d4819ef50fe5036Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$303,701

Program and phase

SBIR · Phase I

Award year

2010

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NDI MEDICAL, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
CJ6SM7L9V314
Solicitation number
PHS2010-2
Topic code
NINDS

Research abstract

DESCRIPTION (provided by applicant): Shoulder pain is a common complication following stroke. A prospective population-based study on first-time stroke patients found that almost one third of patients developed shoulder pain, most describing their pain as moderate to severe. The treatment of shoulder pain is a crucial step towards recovery for stroke survivors. Shoulder pain has been found to lengthen the time to recovery, produce insomnia, and require additional medications or interventions during rehabilitation. The primary objective of this Phase I project is to determine the feasibility of a novel treatment for post-stroke shoulder pain using percutaneous intramuscular electrical stimulation. The first specific aim of this project is to determine the feasibility of the approach. The second specific aim is to evaluate the effect of percutaneous intramuscular electrical stimulation on shoulder pain intensity. The feasibility of reducing pain with intramuscular electrical stimulation will be assessed through the administration of a validated pain questionnaire. Endpoints will be measured at baseline, during and directly following the sham period, and during and directly following the treatment period. A multi-center randomized clinical trial will be executed in a Phase II project. The results of this randomized trial will be used to design a larger pivotal study that will be used to support an FDA pre-market approval (PMA) application for product commercialization. Our long-term objective is to develop a safe and effective neuromodulation treatment for patients with post-stroke shoulder pain. PUBLIC HEALTH RELEVANCE: Each year in the United States, almost one third of the 695,000 new stroke survivors develop shoulder pain, most describing their pain as moderate to severe. The treatment of shoulder pain is an important step towards recovery for stroke survivors, as shoulder pain has been found to interfere with therapeutic exercises, lengthen the time to recovery, produce insomnia, and require additional medications or interventions during rehabilitation. We propose to develop a novel therapy that uses electrical stimulation to treat post-stroke shoulder pain.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

14 SBIR/STTR records share this UEI (2003–2010). Reported award amounts total $4,664,102. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.